Skip to main content
PMC home page
Journal of the Experimental Analysis of Behavior logoLink to Journal of the Experimental Analysis of Behavior
. 1992 Jan;57(1):91–107. doi: 10.1901/jeab.1992.57-91

Low-dose caffeine discrimination and self-reported mood effects in normal volunteers.

K Silverman 1, R R Griffiths 1
PMCID: PMC1323072  PMID: 1548451

Abstract

A caffeine versus placebo discrimination procedure was used to determine the lowest caffeine dose that could produce discrimination and self-reported mood effects in normal volunteers. During daily sessions under double-blind conditions, caffeine-abstinent subjects orally ingested a capsule containing 178 mg caffeine or placebo. Before beginning discrimination training, the compounds were identified to subjects by letter codes. Fifteen, 30, and 45 min after capsule ingestion, subjects guessed the capsule's letter code. Correct guesses at 45 min earned money. After each session, subjects received a supplementary capsule containing caffeine or placebo to ensure that, within each phase of the study, subjects received the same daily dose of caffeine equal to the training dose. Five of the 15 subjects acquired the caffeine versus placebo discrimination within the first 20 sessions (greater than or equal to 75% correct); 6 other subjects acquired the discrimination with additional training. Nine subjects who acquired the discrimination were subsequently trained at progressively lower caffeine doses. In general, the lowest dose to produce discrimination (greater than or equal to 75% correct) was also the lowest dose to produce self-reported mood effects: 4 subjects showed discrimination and self-reported mood effects at 100 mg caffeine, 2 at 56 mg, 1 at 32 mg, and 1 at 18 mg. One of these subjects also showed self-reported mood effects at 10 mg. The present study documents discriminative stimulus and self-reported mood effects of caffeine at doses below those previously shown to affect any behavior in normal volunteers.

Full text

PDF
91

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bickel W. K., Bigelow G. E., Preston K. L., Liebson I. A. Opioid drug discrimination in humans: stability, specificity and relation to self-reported drug effect. J Pharmacol Exp Ther. 1989 Dec;251(3):1053–1063. [PubMed] [Google Scholar]
  2. Chait L. D., Johanson C. E. Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers. Psychopharmacology (Berl) 1988;96(3):302–308. doi: 10.1007/BF00216054. [DOI] [PubMed] [Google Scholar]
  3. Chait L. D., Uhlenhuth E. H., Johanson C. E. An experimental paradigm for studying the discriminative stimulus properties of drugs in humans. Psychopharmacology (Berl) 1984;82(3):272–274. doi: 10.1007/BF00427789. [DOI] [PubMed] [Google Scholar]
  4. Chait L. D., Uhlenhuth E. H., Johanson C. E. The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology (Berl) 1986;89(3):301–306. doi: 10.1007/BF00174364. [DOI] [PubMed] [Google Scholar]
  5. Chait L. D., Uhlenhuth E. H., Johanson C. E. The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans. Pharmacol Biochem Behav. 1986 Jun;24(6):1665–1672. doi: 10.1016/0091-3057(86)90503-4. [DOI] [PubMed] [Google Scholar]
  6. Colpaert F. C., Niemegeers C. J., Janssen P. A. Factors regulating drug cue sensitivity: limits of discriminability and the role of a progressively decreasing training dose in fentanyl-saline discrimination. J Pharmacol Exp Ther. 1980 Mar;212(3):474–480. [PubMed] [Google Scholar]
  7. Griffiths R. R., Bigelow G. E., Liebson I. A. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J Pharmacol Exp Ther. 1986 Nov;239(2):416–425. [PubMed] [Google Scholar]
  8. Griffiths R. R., Bigelow G. E., Liebson I. A. Reinforcing effects of caffeine in coffee and capsules. J Exp Anal Behav. 1989 Sep;52(2):127–140. doi: 10.1901/jeab.1989.52-127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Griffiths R. R., Bigelow G. E., Liebson I. Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry. 1983 Aug;40(8):865–873. doi: 10.1001/archpsyc.1983.01790070055007. [DOI] [PubMed] [Google Scholar]
  10. Griffiths R. R., Evans S. M., Heishman S. J., Preston K. L., Sannerud C. A., Wolf B., Woodson P. P. Low-dose caffeine discrimination in humans. J Pharmacol Exp Ther. 1990 Mar;252(3):970–978. [PubMed] [Google Scholar]
  11. Griffiths R. R., Woodson P. P. Reinforcing effects of caffeine in humans. J Pharmacol Exp Ther. 1988 Jul;246(1):21–29. [PubMed] [Google Scholar]
  12. Hughes J. R., Higgins S. T., Bickel W. K., Hunt W. K., Fenwick J. W., Gulliver S. B., Mireault G. C. Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers. Arch Gen Psychiatry. 1991 Jul;48(7):611–617. doi: 10.1001/archpsyc.1991.01810310029006. [DOI] [PubMed] [Google Scholar]
  13. Jacob P., 3rd, Wilson M., Benowitz N. L. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr. 1981 Jan 2;222(1):61–70. doi: 10.1016/s0378-4347(00)81033-6. [DOI] [PubMed] [Google Scholar]
  14. Lieberman H. R., Wurtman R. J., Emde G. G., Coviella I. L. The effects of caffeine and aspirin on mood and performance. J Clin Psychopharmacol. 1987 Oct;7(5):315–320. [PubMed] [Google Scholar]
  15. Lieberman H. R., Wurtman R. J., Emde G. G., Roberts C., Coviella I. L. The effects of low doses of caffeine on human performance and mood. Psychopharmacology (Berl) 1987;92(3):308–312. doi: 10.1007/BF00210835. [DOI] [PubMed] [Google Scholar]
  16. Overton D. A. Drug discrimination training with progressively lowered doses. Science. 1979 Aug 17;205(4407):720–721. doi: 10.1126/science.462182. [DOI] [PubMed] [Google Scholar]
  17. Preston K. L., Bigelow G. E., Bickel W. K., Liebson I. A. Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther. 1989 Jul;250(1):184–196. [PubMed] [Google Scholar]
  18. Preston K. L., Bigelow G. E., Bickel W., Liebson I. A. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. J Pharmacol Exp Ther. 1987 Dec;243(3):1002–1009. [PubMed] [Google Scholar]
  19. Stern K. N., Chait L. D., Johanson C. E. Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology (Berl) 1989;98(1):81–88. doi: 10.1007/BF00442010. [DOI] [PubMed] [Google Scholar]
  20. Zenick H., Goldsmith M. Drug discrimination learning in lead-exposed rats. Science. 1981 May 1;212(4494):569–571. doi: 10.1126/science.7209554. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Experimental Analysis of Behavior are provided here courtesy of Society for the Experimental Analysis of Behavior

RESOURCES